INTRACAN-130-SB
MRP: 2,500
Packaging: 10x1x10
Pack Type: capsule
Composition:
Itraconazole 130mg (SUBA TACHNOLOGY)
Indication:
Aspergillosis, Cryptococcosis, Sporotrichosis, Candidiasis, Mycosis
Description:
Itraconazole 130 mg capsules with SUBA (Super Bioavailability) Technology offer enhanced absorption and increased effectiveness against a wide range of fungal infections. This oral antifungal medication treats systemic and localized fungal infections such as aspergillosis, blastomycosis, histoplasmosis, and candidiasis. SUBA technology improves bioavailability, ensuring consistent plasma levels for better therapeutic outcomes. The formulation works by inhibiting fungal cell membrane synthesis, effectively stopping fungal growth and proliferation. It is ideal for patients requiring reliable and potent antifungal treatment with improved gastrointestinal tolerance.
Tags:
- Superior bioavailability for enhanced effectiveness
- Treats systemic and localized fungal infections
- Improved gastrointestinal tolerance
- Convenient oral capsule form
- Supports rapid fungal clearance and recovery
Usage Information
Dosage
Follow the prescribing doctor’s instructions precisely Typically taken once or twice daily with food Swallow capsules whole with water Complete the full course even if symptoms improve
Side Effects
Nausea, vomiting, abdominal discomfort Headache, dizziness Possible rash or allergic reaction Rarely, liver function abnormalities (monitor as advised)
Contraindications
Hypersensitivity to itraconazole or formulation ingredients Severe liver impairment or active liver disease Concurrent use with certain drugs metabolized by CYP3A4 (consult doctor) Pregnancy and breastfeeding (use only if benefits outweigh risks)
Availability
Itraconazole 130 mg, SUBA itraconazole, oral antifungal capsules, fungal infection treatment, systemic antifungal, itraconazole bioavailability, itraconazole capsules